drugset / Trial / NCT00340704

PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder

NCT00340704

Phase 2 Completed 143 enrolled Boehringer Ingelheim
RandomizedParallel-groupOpen-labelTreatment

Summary

Aims of this study is to characterize the pharmacokinetic/pharmacodynamic profile and evaluate the safety, efficacy and tolerability, of tamsulosin hydrochloride as treatment in children with a neuropathic bladder, over the course of 12 months of active treatment.

Timeline

Start
2006-04
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Tamsulosin Other / unclassified Oral